Building momentum for malaria vaccine research and development: key considerations
暂无分享,去创建一个
P. Alonso | H. Tinto | P. Bejon | J. Vekemans | D. Schellenberg | C. Chitnis | B. Crabb | S. Herrera | M. Laufer | M. Roestenberg | N. Rabinovich | E. Asturias | K. Collins | Kate O’Brien | Adelaide Shearley | Marian Wentworth
[1] H. Tinto,et al. Building momentum for malaria vaccine research and development: key considerations , 2020, Malaria Journal.
[2] F. Ramos. Report 2019 , 2019, Brazilian Business Review.
[3] M. Laurens. The Promise of a Malaria Vaccine-Are We Closer? , 2018, Annual review of microbiology.
[4] Modelling,et al. malERA: An updated research agenda for combination interventions and modelling in malaria elimination and eradication , 2017, PLoS medicine.
[5] R. Rabinovich,et al. malERA: An updated research agenda for basic science and enabling technologies in malaria elimination and eradication , 2017, PLoS medicine.
[6] A. James,et al. malERA: An updated research agenda for basic science and enabling technologies in malaria elimination and eradication , 2017 .
[7] L. Schuerman,et al. The RTS,S/AS01 malaria vaccine in children 5 to 17 months of age at first vaccination , 2016, Expert review of vaccines.
[8] G. Merenstein. University of Colorado School of Medicine. , 2000, Academic medicine : journal of the Association of American Medical Colleges.